Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 12/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24276712 | 0.93 | NQO2 (0.50) | NQO2MAPTALDH1A1GAARAB9A | |
| SCHEMBL28320380 | 0.90 | NQO2 (0.48) | NQO2MAPTALDH1A1GAARAB9A | |
| SCHEMBL30504380 | 0.88 | NQO2 (0.47) | NQO2MAPTALDH1A1GAARAB9A | |
| SCHEMBL28967302 | 0.88 | NQO2 (0.47) | NQO2MAPTALDH1A1GAARAB9A | |
| SCHEMBL28667228 | 0.84 | NQO2 (0.59) | NQO2MAPTALDH1A1GAARAB9A | |
| SCHEMBL24276707 | 0.84 | NQO2 (0.59) | NQO2MAPTALDH1A1GAARAB9A | |
| SCHEMBL31260124 | 0.84 | NQO2 (0.59) | NQO2MAPTALDH1A1GAARAB9A | |
| SCHEMBL19988780 | 0.82 | NQO2 (0.75) | NQO2MAPTALDH1A1GAARAB9A | |
| SCHEMBL23612578 | 0.80 | ACHE (0.75) | NQO2MAPTALDH1A1GAARAB9A | |
| SCHEMBL15228704 | 0.77 | TDP1 (0.52) | NQO2MAPTALDH1A1GAARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117736153-A | Phenazine derivative, method for producing the same, electron mediator, and sensor | 南京晶捷生物科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| EP-0214330-B1 | METHOD FOR IMMOBILIZING SUBSTANCES IN SYNTHETIC SOLID PHASES, AND SYNTHETIC SOLID PHASES FOR USE IN IMMUNOSORBENT ASSAYS | PROGEN Biotechnik GmbH (DE) | 1989-04-26 | — | — | EP | claimed |
| EP-0214330-A1 | Method for immobilizing substances in synthetic solid phases, and synthetic solid phases for use in immunosorbent assays | PROGEN Biotechnik GmbH (DE) | 1987-03-18 | — | — | EP | claimed |
| CN-121293152-B | Organic light-emitting compound, organic electroluminescent composition, light-emitting device and display device | 季华实验室 | 2026-05-19 | — | — | CN | disclosed |
| US-12060334-B2 | 3-substituted phenazine derivatives as antimicrobial agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-08-13 | — | — | US | disclosed |
| CN-117736153-A | Phenazine derivative, method for producing the same, electron mediator, and sensor | 南京晶捷生物科技有限公司 | 2024-03-22 | — | — | CN | disclosed |
| US-20220289689-A1 | 3-SUBSTITUTED PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2022-09-15 | — | — | US | disclosed |
| CN-111303056-B | Phenazine group-substituted polycyclic aromatic hydrocarbon derivative and application thereof | 北京鼎材科技有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-111253393-B | Long-life triplet exciton confinement material and application thereof in OLED (organic light emitting diode) device | 北京大学 | 2022-01-25 | — | — | CN | disclosed |
| US-11053205-B2 | Phenazine derivatives as antimicrobial agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2021-07-06 | — | — | US | disclosed |
| CN-107915687-B | High-efficiency preparation method of polysubstituted phenazine derivative and oxide thereof | 清华大学 | 2021-02-26 | — | — | CN | disclosed |
| WO-2018152436-A1 | PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS | UNIVERSITY OF RESEARCH FOUNDATION, INCORPORATED (US) | 2018-08-23 | — | — | WO | disclosed |
| US-9856225-B2 | Substituted phenazines as antimicrobial agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2018-01-02 | — | — | US | disclosed |
| WO-2017011730-A2 | PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2017-01-19 | — | — | WO | disclosed |
| US-20160355487-A1 | PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2016-12-08 | — | — | US | disclosed |
| EP-3086791-A2 | PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS | University of Florida Research Foundation, Inc. (US) | 2016-11-02 | — | — | EP | disclosed |
| WO-2016154051-A1 | COMBINATION THERAPY FOR TREATING INFECTIONS DISEASES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2016-09-29 | — | — | WO | disclosed |
| WO-2015100331-A2 | PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-07-02 | — | — | WO | disclosed |
| EP-0214330-B1 | METHOD FOR IMMOBILIZING SUBSTANCES IN SYNTHETIC SOLID PHASES, AND SYNTHETIC SOLID PHASES FOR USE IN IMMUNOSORBENT ASSAYS | PROGEN Biotechnik GmbH (DE) | 1989-04-26 | — | — | EP | disclosed |
| EP-0214330-A1 | Method for immobilizing substances in synthetic solid phases, and synthetic solid phases for use in immunosorbent assays | PROGEN Biotechnik GmbH (DE) | 1987-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289689-A1 | 3-SUBSTITUTED PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS | ROS1, NOX4, NOX5 | NQO2 139/4885MAPT 3143/4885ALDH1A1 348/4885 |
| US-11053205-B2 | Phenazine derivatives as antimicrobial agents | ROS1, NOX4, PRDX3 | NQO2 172/4885MAPT 2601/4885ALDH1A1 701/4885 |
| US-20160355487-A1 | PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS | ROS1, NOX4, NOX5 | NQO2 349/4885MAPT 3475/4885ALDH1A1 1136/4885 |
| US-12060334-B2 | 3-substituted phenazine derivatives as antimicrobial agents | ROS1, NOX4, NOX5 | NQO2 139/4885MAPT 3143/4885ALDH1A1 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.